Recruiting Lung Cancer Studies in Billings
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...
Study of Daraxonrasib (RMC-6236) in Previously Treated Patients With RAS Mutated NSCLC (RASolve 301)
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel....
About Lung Cancer Clinical Trials in Billings
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Billings, MONTANA. These studies are seeking a combined 1,020 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Revolution Medicines, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Billings — FAQ
Are there lung cancer clinical trials in Billings?
Yes, there are 2 lung cancer clinical trials currently recruiting in Billings, MONTANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Billings?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Billings research site will contact you about next steps.
Are clinical trials in Billings free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Billings studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Billings are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov